Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 7651–7700 of 75496
accepted the resignation of Dr. M. Anthony Wong, the independent director, resigning from his position as a director of the Company.
On March 20, 2025, the board of directors of Eureka Acquisition Corp, a Cayman Islands exempted company (the “ Company ”) accepted the resignation of Dr. M. Anthony Wong, the independent director, resigning from his position as a director of the Company.
Concurrently, the Company, by ordinary resolutions of its directors, appointed Mr. Cameron Richard Johnson as the independent director of the Company to fill the vacancy, effective immediately.
On March 18, 2025, the Board of Directors (the “Board”) of the Healthcare Triangle, Inc. (the “Company”) appointed Ms. Sujatha Ramesh to serve as the Company’s Chief Operating Officer, effective immediately.
the Company’s Board of Directors (the “Board”) has appointed Mr. Clark to the Board, effective as of April 25, 2025, pending customary conflict checks.
On March 18, 2025, Randy Clark resigned as President of Vicarious Surgical Inc. (the “Company”), effective as of April 25, 2025.
On March 20, 2025, in connection with the IPO, Sagi Dagan, Omri Cherni, Yevgeny Neginsky, David Bluestein and Kobi Marenko (collectively with Ezra Gardner, the “Directors”) were appointed to the board of directors of the Company (the “Board”).
On March 20, 2025, in connection with the IPO, Sagi Dagan, Omri Cherni, Yevgeny Neginsky, David Bluestein and Kobi Marenko (collectively with Ezra Gardner, the “Directors”) were appointed to the board of directors of the Company (the “Board”).
On March 20, 2025, in connection with the IPO, Sagi Dagan, Omri Cherni, Yevgeny Neginsky, David Bluestein and Kobi Marenko (collectively with Ezra Gardner, the “Directors”) were appointed to the board of directors of the Company (the “Board”).
On March 20, 2025, in connection with the IPO, Sagi Dagan, Omri Cherni, Yevgeny Neginsky, David Bluestein and Kobi Marenko (collectively with Ezra Gardner, the “Directors”) were appointed to the board of directors of the Company (the “Board”).
On March 20, 2025, in connection with the IPO, Sagi Dagan, Omri Cherni, Yevgeny Neginsky, David Bluestein and Kobi Marenko (collectively with Ezra Gardner, the “Directors”) were appointed to the board of directors of the Company (the “Board”).
On March 20, 2025, in connection with the IPO, Sagi Dagan, Omri Cherni, Yevgeny Neginsky, David Bluestein and Kobi Marenko (collectively with Ezra Gardner, the “Directors”) were appointed to the board of directors of the Company (the “Board”).
On March 17, 2025, the board of directors (the “Board”) appointed Ms. Xian Nan (Delia) Zheng (“Ms. Zheng”) as the new Chief Financial Officer.
On March 17, 2025, Mr. Xue Zhi Ma resigned as CFO of Summit Networks Inc. (the “Company”).
Effective March 21, 2025, the board of directors of the Company (the “Board”) appointed Jamila Mayfield, age 43, as a director of the Company.
On March 21, 2025, the Board appointed Monica Kelsey as Chief Financial Officer of the Company effective as of the close of business on March 21, 2025.
On March 20, 2025, Venugopal Rathi notified the Board of Trustees (the “Board”) of the Company of his resignation as the Company’s Chief Financial Officer.
the Board appointed Monica Kelsey as Chief Financial Officer of the Company effective as of the close of business on March 21, 2025.
Venugopal Rathi notified the Board of Trustees (the “Board”) of Antares Strategic Credit Fund (the “Company”) of his resignation as the Company’s Chief Financial Officer.
On March 18, 2025, Carissa Rollins, Chief Information Officer, notified Illumina, Inc. that she will be retiring effective as of April 11, 2025.
On March 20, 2025, James J. Gosa resigned as Executive Vice President and Chief Commercial Officer of Beacon Roofing Supply, Inc., effective immediately.
appointed Carl Russell (“Buck”) Fletcher IV, an employee of FIG LLC, our external manager (our “Manager”), as the Company’s Chief Financial Officer and Chief Accounting Officer, effective immediately.
Mr. Fletcher succeeds Scott Christopher, the Company’s current Chief Financial Officer and Chief Accounting Officer, who will cease serving in such roles effective immediately.
Mr. Mathewes will return from the leave of absence and resume his duties and responsibilities effective March 24, 2025.
Ms. Day will cease serving as acting Chief Financial Officer and will continue serving as the Company's Executive Vice President, Finance.
On March 21, 2025, following Ms. Wojcicki’s resignation and effective as of the Resignation Effective Time, the Board appointed Joseph Selsavage, the Company’s current Chief Financial and Accounting Officer, as Interim Chief Executive Officer and Interim President.
On March 21, 2025, Anne Wojcicki, the Company’s Chief Executive Officer and President, by mutual agreement between Ms. Wojcicki and the Special Committee, tendered her resignation as an officer of the Company to the Board, which such resignation was effective at 5:00 p.m., Eastern Time, on March 23, 2025
On March 21, 2025, the Board increased the size of the Board from four members to five members (the “Board Increase”) in accordance with the Company’s Second Amended and Restated Bylaws and Certificate of Incorporation, as amended, and appointed Thomas B. Walper as a non-employee director of the Board
Effective March 21, 2025, the Board increased the size of the Board from eight (8) to eleven (11) directors and appointed each of Mr. Mohamed and Mr. Burns as directors, effective no later than April 15, 2025.
Effective March 21, 2025, the Board increased the size of the Board from eight (8) to eleven (11) directors and appointed each of Mr. Mohamed and Mr. Burns as directors, effective no later than April 15, 2025.
Additionally, the Board approved the appointment of Mr. Galligan as a director contingent upon receipt of a written request from JANA pursuant to the Cooperation Agreement, effective no later than 45 business days following March 21, 2025.
In connection with the Transactions, Karen King, John Suo and Mark Shapiro were appointed to the Board, effective as of the Effective Time.
In connection with the Transactions, Karen King, John Suo and Mark Shapiro were appointed to the Board, effective as of the Effective Time.
In connection with the Transactions, Karen King, John Suo and Mark Shapiro were appointed to the Board, effective as of the Effective Time.
In connection with the Transactions, each of Fawn Weaver, Ursula Burns and Jacqueline Reses resigned from the board of directors of the Company (the “Board”) and the committees thereof on which they serve, effective as of the Effective Time.
In connection with the Transactions, each of Fawn Weaver, Ursula Burns and Jacqueline Reses resigned from the board of directors of the Company (the “Board”) and the committees thereof on which they serve, effective as of the Effective Time.
In connection with the Transactions, each of Fawn Weaver, Ursula Burns and Jacqueline Reses resigned from the board of directors of the Company (the “Board”) and the committees thereof on which they serve, effective as of the Effective Time.
It was determined that Mr. Scott Vollet, Executive Vice President, Global Operations of Tempur Sealy International, will no longer function as an executive officer or Section 16 insider for purposes of Section 16 of the Securities Exchange Act of 1934, as amended.
The board of directors (the “Board”) of the Company has determined that Mr. Jack Acosta, who is currently a Class II director, will not be nominated to stand for re-election as a Class II director at the Annual Meeting.
The Board accepted Mr. Mariner’s resignation, reduced Class III to three members, increased Class II to four members and immediately reappointed Mr. Mariner as a Class II director with a term set to expire at the Annual Meeting.
In connection with his promotion to interim President of the Company and interim Chief Executive Officer and President of the Bank, the Committee increased his previously-approved annual base salary from $485,000 to $550,000
O n March 18, 2025, Beth A. Zayicek, one of our executive directors, notified us of her resignation from Invesco Ltd., effective May 23, 2025. Ms. Zayicek will continue to serve as a member of our board of directors through her current term, which ends on May 6, 2025, but will not seek re-election at the 2025 annual stockholders meeting.
The Company has announced that Danielle Rangel, current Vice President of Internal Audit and Investigations, has been promoted to succeed Ms. Gagnon as Vice President and Chief Accounting Officer effective May 2, 2025.
On March 19, 2025, Amy Gagnon, Vice President and Chief Accounting Officer for the Company, notified the Company that she will be stepping down from her role as Chief Accounting Officer effective May 2, 2025, in order to attend to personal family obligations.
appointed Michael Hanson as a director of the Company to fill such newly created vacancy on March 19, 2025, effective immediately
Talya Nevo-Hacohen, the Company’s Executive Vice President, Chief Investment Officer and Treasurer, has decided to retire from Sabra, effective December 31, 2025
Darrin Smith, Sabra’s Executive Vice President – Investments, is expected to assume this position effective January 1, 2026.
Jeffrey Dierks will be departing from the Company as its Chief Commercial Officer, effective as of March 31, 2025 (the “Effective Date”), for personal reasons.
On March 21, 2025, Elicio Therapeutics, Inc. (the “Company”) appointed Preetam Shah, Ph.D., M.B.A., as the Company’s Chief Strategy and Financial Officer effective as of March 24, 2025 (the “Effective Date”).
On March 19, 2025, David Zinsner, a member of the board of directors (the "Board") of Credo Technology Group Holding Ltd (the "Company"), resigned from the Board, effective March 19, 2025.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.